Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Coherus Bio (CHRS)

Coherus Bio (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why Coherus Biosciences Stock Tumbled on Thursday

The company fell well short of expectations for its fourth quarter.

CHRS : 2.39 (-1.24%)
Coherus BioSciences: Q4 Earnings Snapshot

Coherus BioSciences: Q4 Earnings Snapshot

CHRS : 2.39 (-1.24%)
Why Coherus BioSciences Stock Jumped Today

As promised, Coherus is using the proceeds of a recent divestiture to pay down debt and reduce interest expenses.

CHRS : 2.39 (-1.24%)
Why Coherus BioSciences Stock Is Sinking Today

The positive reaction to Coherus' sale of its ophthalmology franchise to Sandoz didn't last long.

CHRS : 2.39 (-1.24%)
Why Coherus Biosciences Popped Today

Coherus is divesting its non-core ophthalmology franchise.

SDZNY : 30.1000 (+2.42%)
CHRS : 2.39 (-1.24%)
Why Coherus BioSciences Stock Jumped Today

Coherus finally received FDA approval for its Udenyca OnBody injector system.

CHRS : 2.39 (-1.24%)
Cytokinetics, New York Times rise; Iovance Biotherapeutics fall, Wednesday, 12/27/2023

Stocks that are trading heavily or have substantial price changes on Wednesday: Cytokinetics, New York Times rise; Iovance Biotherapeutics fall

CYTK : 70.11 (-1.82%)
NEM : 35.84 (+1.67%)
TMUS : 163.22 (+0.75%)
FCX : 47.02 (+2.48%)
TM : 251.68 (-0.19%)
CHRS : 2.39 (-1.24%)
NYT : 43.22 (-1.93%)
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street

These two biotech stocks could be poised for a trend reversal.

BMY : 54.23 (+1.84%)
AGEN : 0.5800 (+4.24%)
CHRS : 2.39 (-1.24%)
Why Coherus BioSciences Was Plummeting This Week

The company has been punished harshly for a worse-than-expected quarter.

TFC : 38.98 (+1.01%)
CHRS : 2.39 (-1.24%)
Why Coherus Biosciences Stock Dropped Today

Coherus missed estimates for the third quarter and lowered its full-year outlook.

CHRS : 2.39 (-1.24%)

Barchart Exclusives

Ford Motor vs. Toyota: Which Hybrid EV Stock Is a Better Buy?
With hybrid EVs gaining popularity, let’s find out whether shares of Ford or Toyota are a better buy. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar